Project Search Results


Research Categorization


Project Details


Contact Researcher and Awardee Organization


Funding Organization

Displaying 1 - 10 of 17 Projects
Project # Contact PI Funding Organization Fiscal Year
Testing low-dose efavirenz treatment for Alzheimer’s disease: a phase 1b dosing, target-engagement and exploratory biomarker study.
ADDF-48 SCHELTENS, PHILIP Alzheimer's Drug Discovery Foundation 2021
Single-cell molecular mapping of adult neurogenesis in Alzheimer’s disease
WE.03-2020-04 Evgenia Salta Alzheimer Nederland 2020
Understanding the role of newly identified pre-tangle associated proteins in AD
WE.03-2020-09 David Hondus Alzheimer Nederland 2020
A novel microscopy approach to study amyloid beta production in live cells
WE.03-2019-10 Judith Klumperman Alzheimer Nederland 2019
Multiple nuclear receptor activation in the treatment of Alzheimer’s disease
WE.03-2018-06 MULDER, MONIQUE T. Alzheimer Nederland 2018
A Phase IIa Trial to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of TW001 in Alzheimer Patients
GC-2013807 van der Geest, Ronald Alzheimer's Drug Discovery Foundation 2018
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
α7 Subunit containing nAChR antagonism and the interaction with amyloidβ in AD
WE.03-2017-11 VANMIERLO, Tim Alzheimer Nederland 2017
Symptomatic Treatment of Vascular Cognitive Impairment
EUJPND-AlzNederland-Prins-1627 Prins, N.P. Alzheimer Nederland 2016
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016